Essential Role for Oxidative Phosphorylation in Cancer Progression
TLDR
It is demonstrated that only mtDNA-depleted cancer cells capable of recovering mtDNA from the host form metastasizing cancers in vivo, revealing an essential requirement for oxidative phosphorylation in tumor progression.About:
This article is published in Cell Metabolism.The article was published on 2015-01-06 and is currently open access. It has received 44 citations till now. The article focuses on the topics: Tumor progression & Cancer.read more
Citations
More filters
Journal ArticleDOI
The interplay between cell signalling and the mevalonate pathway in cancer
Peter J. Mullen,Rosemary Yu,Rosemary Yu,Joseph Longo,Joseph Longo,Michael C. Archer,Linda Z. Penn,Linda Z. Penn +7 more
TL;DR: This Review summarizes recent advances and discusses unique opportunities for immediately targeting this metabolic vulnerability in cancer with agents that have been approved for other therapeutic uses, such as the statin family of drugs, to improve outcomes for cancer patients.
Journal ArticleDOI
Metformin in patients with advanced pancreatic cancer: a double-blind, randomised, placebo-controlled phase 2 trial
Sil Kordes,Michael Pollak,Aeilko H. Zwinderman,Ron A. A. Mathôt,Mariëtte J. Weterman,Aart Beeker,Cornelis J. A. Punt,Dick J. Richel,Johanna W. Wilmink +8 more
TL;DR: Addition of a conventional anti-diabetic dose of metformin does not improve outcome in patients with advanced pancreatic cancer treated with gemcitabine and erlotinib and future research should focus on patients with hyperinsulinaemia and patients with tumours showing markers of sensitivity to energetic stress.
Journal ArticleDOI
Targeting glucose metabolism to suppress cancer progression: prospective of anti-glycolytic cancer therapy.
TL;DR: This review aimed to present the most recent data on the emerging drug candidate targeting enzymes and intermediates involved in glucose metabolism to provide therapeutic opportunities and challenges for antiglycolytic cancer therapy.
Journal ArticleDOI
Fatty Acid Oxidation-Driven Src Links Mitochondrial Energy Reprogramming and Oncogenic Properties in Triple-Negative Breast Cancer
Jun Hyoung Park,Sajna Antony Vithayathil,Santosh Kumar,Pi Lin Sung,Pi Lin Sung,Lacey E. Dobrolecki,Vasanta Putluri,Vadiraja B. Bhat,Salil Kumar Bhowmik,Vineet Gupta,Kavisha Arora,Danli Wu,Efrosini Tsouko,Yiqun Zhang,Suman Maity,Taraka R. Donti,Brett H. Graham,Daniel E. Frigo,Daniel E. Frigo,Cristian Coarfa,Patricia Yotnda,Nagireddy Putluri,Arun Sreekumar,Michael T. Lewis,Chad J. Creighton,Lee-Jun C. Wong,Benny Abraham Kaipparettu +26 more
TL;DR: Analysis of cybrids and established breast cancer cell lines showed that metastatic TNBC maintains high levels of ATP through fatty acid β oxidation (FAO) and activates Src oncoprotein through autophosphorylation at Y419, and confirmed the role of mitochondrial FAO in Src activation and metastasis.
Journal ArticleDOI
Modeling the Genetic Regulation of Cancer Metabolism: Interplay between Glycolysis and Oxidative Phosphorylation
Linglin Yu,Mingyang Lu,Dongya Jia,Jianpeng Ma,Jianpeng Ma,Eshel Ben-Jacob,Eshel Ben-Jacob,Herbert Levine,Benny Abraham Kaipparettu,José N. Onuchic +9 more
TL;DR: It is proposed that the hybrid phenotype contributes to metabolic plasticity, allowing cancer cells to adapt to various microenvironments, and design cancer therapies targeting metabolism.
References
More filters
Journal ArticleDOI
Mitochondria and cancer
TL;DR: Cancer cells then reprogramme adjacent stromal cells to optimize the cancer cell environment and activate out-of-context programmes that are important in development, stress response, wound healing and nutritional status.
Journal ArticleDOI
Oncogene ablation-resistant pancreatic cancer cells depend on mitochondrial function
Andrea Viale,Piergiorgio Pettazzoni,Costas A. Lyssiotis,Haoqiang Ying,Nora S. Sanchez,Matteo Marchesini,Alessandro Carugo,Tessa Green,Sahil Seth,Virginia Giuliani,Maria Kost-Alimova,Florian L. Muller,Simona Colla,Luigi Nezi,Giannicola Genovese,Angela K. Deem,Avnish Kapoor,Wantong Yao,Emanuela Brunetto,Ya'an Kang,Min Yuan,John M. Asara,Y. Alan Wang,Timothy P. Heffernan,Alec C. Kimmelman,Huamin Wang,Jason B. Fleming,Lewis C. Cantley,Ronald A. DePinho,Giulio Draetta +29 more
TL;DR: It is demonstrated that a subpopulation of dormant tumour cells surviving oncogene ablation (surviving cells) and responsible for tumour relapse has features of cancer stem cells and relies on oxidative phosphorylation for survival.
Journal ArticleDOI
Mitochondrial mutations in cancer.
TL;DR: The mtDNA mutations in tumors may fall into two main classes: (1) severe mutations that inhibit OXPHOS, increase reactive oxygen species (ROS) and promote tumor cell proliferation and (2) milder mutations that may permit tumors to adapt to new environments.
Journal ArticleDOI
Human mitochondrial DNA: roles of inherited and somatic mutations
TL;DR: Insight into the roles of mtDNA mutations in a wide variety of diseases is discussed, highlighting the interesting genetic characteristics of the mitochondrial genome and challenges in studying its contribution to pathogenesis.
Journal ArticleDOI
Metabolic targets for cancer therapy
Lorenzo Galluzzi,Lorenzo Galluzzi,Oliver Kepp,Matthew G. Vander Heiden,Matthew G. Vander Heiden,Guido Kroemer +5 more
TL;DR: The intimate relationship between metabolism and malignancy is discussed, focusing on strategies through which this central aspect of tumour biology might be turned into cancer's Achilles heel.
Related Papers (5)
Mitochondrial Genome Acquisition Restores Respiratory Function and Tumorigenic Potential of Cancer Cells without Mitochondrial DNA
An S. Tan,James W. Baty,Lan-Feng Dong,Ayenachew Bezawork-Geleta,Berwini Endaya,Jacob Goodwin,Martina Bajzikova,Jaromira Kovarova,Martin Peterka,Bing Yan,Elham Alizadeh Pesdar,Margarita Sobol,Anatolyj Filimonenko,Shani Stuart,Magdalena Vondrusova,Katarina Kluckova,Karishma Sachaphibulkij,Jakub Rohlena,Pavel Hozák,Jaroslav Truksa,David Eccles,Larisa M. Haupt,Lyn R. Griffiths,Jiri Neuzil,Jiri Neuzil,Michael V. Berridge +25 more
Oncogene ablation-resistant pancreatic cancer cells depend on mitochondrial function
Andrea Viale,Piergiorgio Pettazzoni,Costas A. Lyssiotis,Haoqiang Ying,Nora S. Sanchez,Matteo Marchesini,Alessandro Carugo,Tessa Green,Sahil Seth,Virginia Giuliani,Maria Kost-Alimova,Florian L. Muller,Simona Colla,Luigi Nezi,Giannicola Genovese,Angela K. Deem,Avnish Kapoor,Wantong Yao,Emanuela Brunetto,Ya'an Kang,Min Yuan,John M. Asara,Y. Alan Wang,Timothy P. Heffernan,Alec C. Kimmelman,Huamin Wang,Jason B. Fleming,Lewis C. Cantley,Ronald A. DePinho,Giulio Draetta +29 more